Comments submitted to FDA on Rare Diseases: Common Issues in Drug Development.(Docket Number: FDA-2015-D-2818-0001).
Regulatory Comments
Comments submitted to FDA on Rare Diseases: Common Issues in Drug Development.(Docket Number: FDA-2015-D-2818-0001).